about
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle p...
Read More
35.33
-2.02
(-5.41%)
3.2M
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Cytokinetics Inc is on 02 Sep 2025 for the purpose of Primary results from MAPLE-HCM
See details
Not Eligible
Expensive Valuation
Technically Neutral
Cytokinetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..